Results of network meta-analyses of efficacy outcomes (A and B) for all anti-VEGF drugs relative to each other under the CME pattern.

Abbreviations: Afl, Aflibercept; BCVA, best-corrected visual acuity; Be, Bevacizumab; CIs, confidence intervals; CME, cystoid macular edema; CMT, central macular thickness; Con, Conbercept; OCT, optical coherence tomography; Ran, Ranibizumab; Sha, sham.

缩写对照表：Afl，阿柏西普（Aflibercept）；BCVA，最佳矫正视力（best-corrected visual acuity）；Be，贝伐珠单抗（Bevacizumab）；CIs，置信区间（confidence intervals）；CME，囊样黄斑水肿（cystoid macular edema）；CMT，中心黄斑厚度（central macular thickness）；Con，康柏西普（Conbercept）；OCT，光学相干断层扫描（optical coherence tomography）；Ran，雷珠单抗（Ranibizumab）；Sha，假治疗（sham）。